[1]
|
Korth, R.M. (2006) Gender obesity, alcohol use, hyper- lipide-mia, hypertension and decline of renal endothelial barriers, Journal of Men’s Health and Gender, 3, 279-289.
doi:10.1016/j.jmhg.2005.08.006
|
[2]
|
Korth, R.M. (2002) AHA-syndromes, Chemistry Physics of Lipids, 118, 96-97.
|
[3]
|
Korth, R., Zimmermann, K. and Richter, W. (1994) “Lipoprotein-associated paf (LA-paf) was found in washed human platelets and monocyte-macrophage-like U937 cells. Chemistry Physic of Lipids, 70, 109-119.
doi:10.1016/0009-3084(94)90079-5
|
[4]
|
Korth, R.M. (2000) Comparison of phosphocholines in human plasma and cere-brospinal fluid (CSF). The Faseb Journal, 14, A72.
|
[5]
|
Korth, R., Bidault, J., Palmatier, R., Beneveniste J. and Ninio, E. (1993) Human platelets release a paf-acether: Acetylhydrolase similar to that in plasma, Lipids, 28, 193-199. doi:10.1007/BF02536639
|
[6]
|
Korth, R.M. (1997) VLDL and PAF binding to human endothelial cells. Chemistry and Phys-ics of Lipids, 88, 134.
|
[7]
|
Korth, R.M. (2005) Gender dyslip-idemia and ether phos- pholipids, The Faseb Journal, 19, 109.
|
[8]
|
Korth, R.M. (2007) Obesity mediated hypertension while alcohol use declined renal endothelial barriers of women. The Faseb Journal, 21, A1361.
|
[9]
|
Barzilay, J.J., Peterson, D., Cushman, M., Heckbert, S.R., Cao, J.J., Blaum, C., Tracy, R.P., Klein, R. and Herrington, D.M. (2004) The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension. The Car-diovascular Health Study, American Kidney Disease, 44, 25-34.
doi:10.1053/j.ajkd.2004.03.022
|
[10]
|
Vasan, R.S. (2005) Rela-tive importance of borderline and elevated levels of coronary heart disease risk factors. Annals of Internal Medicine, 142, 393-402.
|
[11]
|
Berenson, G.S., Srinivasan, S.R., Bao, W., Newmann, W.P., Tracy, R.E. and Wattigney, W.A. (1998) Associa- tion between multiple cardiovascular risk factors and atherosclerosis in children and young adults, New England Journal of Medicine, 338, 1650-1656.
doi:10.1056/NEJM199806043382302
|
[12]
|
Sanyal, A.J., Cha-lasani, N., Kowdley, K.V., McCullough, A., Diel, A.M., Bass, N.M., Neuschwander-Tetri, B.A., Lavine, J.E., Tonascia, J., Unalp, A., Van Natta, M., Clark, J., Brunt, E.M., Kleiner, D.E., Hoofnagle, J.H. and Robuck, P.R. (2010) Pioglitazone, Vitamin E, or placebo for nonalcoholic steatohepatitis. New Engand Journal of Me- dicine, 362, 1675-1685. doi:10.1056/NEJMoa0907929
|
[13]
|
Coustan, D.R., Lowe, L.P., Metzger, B.E. and Dyer, A.R. (2007) The hyperglycemia and adverse pregnany outcome (paving the way for new diagnostic criteria for gestational diabetes mellitus). American Journal Obstetic and Gyne- cology, 202, 654-657.
|
[14]
|
Gupta, B.P., Murad, M.H., Clifton, M.M., Prokop, L., Nehra, A. and Ko-pecky, S.L. (2011) “The effect of life- style modification and cardiovascular risk factor reduc- tion on erectil dysfunction: a systemic review and meta-analyis. Archives Internal Medicine, 171, 1797-17803.
doi:10.1001/archinternmed.2011.440
|
[15]
|
Bertoiy, M.L., Waring, M.E., Gupta, P.S., Roberts, M.B. and Eaton, C.B. (2011) “Hypertension Guidelines Implications. Hypertension, 58, 361-366.
doi:10.1161/HYPERTENSIONAHA.111.175463
|
[16]
|
Querzfurth, H.W. (2010) Mechanism of disease Alzhei- mer’ disease. New England Journal Medicine, 362, 329- 344.
|
[17]
|
Korth, R.M., Hirafuji, M., Beneveniste, J. and Russo-Marie, F. (1995) Human umbilical vein endothelial cells: Specific binding of platelet-activating factor and cytosolic calcium flux. Biochemical Pharmacology, 49, 1793-1799.
doi:10.1016/0006-2952(95)00025-U
|
[18]
|
Hiramoto, M., Yo-shida, H., Imaizumi, T., Yoshimizu, N. and Satoh, K. (1997) A mutation in plasma platetet activating factor acetylhydrolases (VAL279-Phe) is a genetic risk factor for stroke. Stroke, 28, 2417-2420.
doi:10.1161/01.STR.28.12.2417
|
[19]
|
Wen, X.Y., Hegele, R.A., Wang, J., Wang, D.Y., Cheung, J., Wilson, M., Yanyapour, M., Bai, Y., Zhuang, L., Skaug, J., Young, T.K., Conelly, P.W., Koop, B.F., Tsui, L.C. and Stewart, A.K. (2003) Identification of a novel lipase gene mutated in lpd mice wth hypertriglyceridemia and associated with dyslipidemia in humans. Human Molecular Genetics, 12, 1131-1143. doi:10.1093/hmg/ddg124
|
[20]
|
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennachio, L.A., Boerwinkle, E., Cohen, J.C. and Hobbs, H. (2008) “Genetic variation in PNPLA3 confess susceptibility to nonalcoholic fatty liver disease. Nature Genetics, 40, 1461-1465. doi:10.1038/ng.257
|
[21]
|
Sacks, F.M., Svetkey, L.P., Vollmer, W.M., Appel, L.J., Bray, G.A., Harsha, D., Obarzanek, E., Conlin, P.R., Miller, E.R., Simons-Morton, D.G., Karanja, N. and Lin, P.H.L.N. (2001) “DASH-Sodium Collaboration Re-search Group. Effects on blood pressure of reduced dietary so- dium and the dietary approaches to stop hypertension (DASH) diet. New England Journal Medicine, 344, 3-10.
doi:10.1056/NEJM200101043440101
|
[22]
|
Volek, J.S., Fer-nandez, M.L., Feinman, R.D. and Phinney, S.D. (2008) Dietary carbohydrate restriction induces a unique metablic state positively affecting atherogenic dy- slipidemia, fatty acid partioning, and metabolic syndrome. Progress in Lipid Research, 47, 307-318.
doi:10.1016/j.plipres.2008.02.003
|
[23]
|
Humphries, S. (2011) Task force for the management of dyslipidemias of the European Society of Cardiology and the European Atherosclerosis Society. Atherosclerosis, 21751.
|
[24]
|
Kraus, A.R. (2008) Alkoholkonsum, alkoholbezogene probleme und trends. Ergeb-nisse des epidemiologischen suchtsurvey 2003. Robert Koch Institut, Gesundheitsberichterstattung des Bundes, 40.
|
[25]
|
Korth, R.M. (2000) www.fidabus.com
|
[26]
|
Korth, R.M. (2001) www.fidaaha.com
|